SEC Form 4 Filing Summary for Kush Parmar

Kush Parmar, a 10% owner and director of Entrada Therapeutics, Inc. (TRDA), reported the sale of 114,756 shares of common stock on July 30, 2026, at a weighted average price of $6.93 per share. The sales occurred in multiple transactions at prices ranging from $6.75 to $6.95. Following this transaction, Parmar indirectly owns 2,848,310 shares. An additional sale of 1,718 shares occurred on July 31, 2026, at $6.85 per share, resulting in 2,846,592 shares held indirectly. The shares are held through various entities, including 5AM Ventures V, L.P. and 5AM Opportunities I, L.P., with Parmar potentially sharing voting and investment power.